For the past four decades, benefit-cost analyses have been an essential part of the regulatory development process in U.S. agencies. With the advent of the Trump Administration, this procedural cornerstone has been significantly impacted due to an aggressive deregulatory strategy. Moreover, a shrinking federal workforce and budgetary constraints have further complicated the execution of these crucial analyses, particularly those aiming to determine the negative and positive impacts of potential policies.
Benefit-cost analysis, as a long-standing framework, allows for a methodical exploration of policy impacts, encompassing all facets that are either in favor of or against a proposal. These analyses strive to compile accessible evidence along with the adjoining uncertainties. Such a systematic approach even includes the evaluation of hard-to-quantify factors, unveiling unanticipated consequences, and highlighting potential sources of support or dissent.
Informed decision making is fundamental to the progression of any administration. Thus, the requirement for these analyses has been consistently maintained across both Democratic and Republican administrations, albeit with intermittent modifications or addendums. Highlighted within Executive Order 12,866, this regulatory philosophy’s bedrock principle is clear—federal agencies should issue regulations only when commanded by law, required for the interpretation of law, or compelled by a pressing public demand.
Capitalizing on his first 100 days in office, President Trump issued several executive orders that inevitably shaped future regulatory development. Along with the retraction of the revised guidance for conducting benefit-cost analyses, the initiation of new regulatory prerequisites for deregulation and an expanded requirement for independent agencies to conduct benefit-cost analyses, comprise three key changes affecting these regulatory underpinnings.
Post the 2023 review and consultation, the 2003 model of Circular A-4 was reinstated. The ambiguity persists, however, about whether Trump’s administration will introduce its own revision subsequent to this reinstatement. There’s a pressing need for an update, given the evolution of data and methodologies associated with benefit-cost analysis over the past two decades.
Moreover, substantial non-compliance persists within agencies regarding the analytical requirements of Circular A-4. This inadequacy remained unresolved over both the 2003 and 2023 iterations of Circular A-4. Such non-compliance suggests a sporadic enforcement of Executive Order 12,866 and Circular A-4 requirements, creating an inconsistent regulatory environment.
This uneven enforcement could partially stem from analytical hurdles, but also likely has roots in political apprehension. Conduction of any analysis escalates the risk of unearthing issues that an agency may lack the authority or political willpower to tackle. Moreover, if the resultant regulation aligns with an administration’s ideology or policy goals but the analysis suggests an alternative with larger net benefits, it can fuel resistance.
Additionally, the Trump administration’s emphatic drive towards deregulation presents additional deterrents to full compliance with the benefit-cost analysis requirements. This was visible when President Trump issued Executive Order 14,192, a more stringent successor to Executive Order 13,771.
Executive Order 14,192 necessitates the elimination of ten existing regulations for each new regulation issued. It also introduces a much stricter cap on regulatory costs. Further stipulations of this executive order allow the elimination of both regulatory and non-regulatory actions to offset new regulations.
Significantly, only half of the major regulations dictated by Executive Order 12,866 were coupled with accurate estimates of benefits and costs. Owing to the present administration’s cost-reduction drive and significant cutbacks on regulatory agencies’ staffing and budgets, it is prudent to expect a decline in benefits assessment.
Lastly, the extension of regulation analysis requirements to independent agencies is another notable initiative. In April, a memorandum was issued by OMB to guide the implementation of Executive Order 14,215. The impacts of these new requirements on independent agencies’ practices are yet to be seen, considering they may face similar challenges as those subject to Executive Order 12,866.
In conclusion, administrations across the political spectrum have upheld a cautious approach to regulation for over 40 years. Regulations are implemented when there is a justified necessity, and when the benefits outweigh the costs. However, the interpretation and application of this philosophy vary significantly.
Circular A-4 insists that simply adhering to a formula does not equate to proper regulatory analysis. Quality analysis requires specialized professional judgment. Given current constraints of resources and time, cultivating that judgment poses a considerable challenge.
Further systematic analysis requires a substantial investment of personnel, funds, and time. In the prevailing climate of reduced resources, ensuring that comprehensive analysis continues to underpin policy decision-making is a formidable challenge.
The scale of influence benefit-cost analyses have had on policy-making cannot be understated. The Trump Administration’s aggressive deregulatory strategy and budgetary constraints have challenged these analytical methods. Despite these hurdles, maintaining the integrity of this system is vital to transparent, informed decision-making in the future.
The post Aggressive Deregulation Under Trump Puts Strain on Analytical Processes appeared first on Real News Now.
About Author
